| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |